COMMUNIQUÉS West-GlobeNewswire

Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of acute myeloid leukemia (AML)

11/01/2018 - 15:00

Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of acute myeloid leukemia (AML) Lugano, Switzerland and San Diego, USA, [...]

HealthEC Earns Highest Overall Satisfaction Rating in KLAS Research’s Population Health Management 2017 Report

11/01/2018 - 15:00

PISCATAWAY, N.J., Jan. 11, 2018 (GLOBE NEWSWIRE) -- HealthEC customers reported being “very satisfied” in nearly all of the functionality verticals and helped the company earn a 94.2* overall performance score in the [...]

Olainfarm Holds Third Quarter 2017 and Latest Corporate News Investor Conference Webinar

11/01/2018 - 15:00

Olaine, 2018-01-11 15:00 CET (GLOBE NEWSWIRE) -- Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš will inform about [...]

Lexington Biosciences Announces Exercise of Warrants

11/01/2018 - 15:00

VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce that [...]

Endonovo Therapeutics Engages ShareIntel, A Leader In Shareholder Intelligence Services To Investigate Market Maker and Clearing Firm Irregularities

11/01/2018 - 15:00

LOS ANGELES, CA, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a clinical-stage developer of non-invasive electroceuticals for the treatment of central [...]

Pacgen Announces Private Placement Financing and Appointment of New Director

11/01/2018 - 15:00

VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Pacgen Life Science Corporation (“Pacgen” or the “Company”) (TSX-V: PBS ) announced today that it has completed a non-brokered private placement of 12,300, [...]

Tower One Annual Update

11/01/2018 - 15:00

VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp. (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces achievements from its first year operating as a [...]

Virbac : bilan semestriel contrat de liquidité au 31 décembre 2017

11/01/2018 - 14:41

Carros, le 10 janvier 2018 BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE Au titre du contrat de liquidité confié par la société VIRBAC S.A. à la société EXANE BNP PARIBAS, les moyens suivants figuraient au [...]

Cannabis Wheaton Income Corp. Announces Level Ten Inc. as New Wheaton Streaming Partner

11/01/2018 - 14:30

VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is pleased to announce that it has entered into a [...]

Hemispherx Enhances Manufacturing Efficiency of Ampligen

11/01/2018 - 14:30

ORLANDO, Fla., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), has successfully tested a new chemical catalyst used in the manufacturing process of Ampligen®, a novel molecule currently [...]

BLVD Centers Announces California Marijuana Treatment Initiative, Appoints new Chief Financial Officer

11/01/2018 - 14:30

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, Jan. 11, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (“ BLVD Centers ” or the “ Company ”) (TSXV:CXV [...]

Abattis Enters Into Definitive Agreement to Acquire Green Tree Therapeutics

11/01/2018 - 14:28

VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news releases dated December 22, [...]

Preferred Dental Technologies Inc. (“Company”) (CSE: PDTI): announces President Erik Siegmund interviewed by industry leading research firm

11/01/2018 - 14:10

WINNIPEG, Manitoba, Jan. 11, 2018 (GLOBE NEWSWIRE) -- PDTI (CSE:PDTI) today announced that they were mentioned by name in the latest leading dental 3D printing research report titled 3D Printing in Dentistry 2018 issued [...]

Long Island Plastic Surgeons Launch Website for Hand Reconstruction

11/01/2018 - 14:00

GARDEN CITY, N.Y., Jan. 11, 2018 (GLOBE NEWSWIRE) -- The Institute for Hand Surgery at Long Island Plastic Surgical Group (LIPSG) is dedicated to helping people restore form and function that have been affected by [...]

Golden Leaf Holdings Announcement of Jackson & Company as New Independent Auditor

11/01/2018 - 14:00

TORONTO, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced the [...]

Extendicare Announces the Renewal of its Normal Course Issuer Bid

11/01/2018 - 14:00

MARKHAM, Ontario, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today that it has received the approval of the Toronto Stock Exchange (the “TSX”) to renew its [...]

DLT Resolution Enters Canadian Market, Records First Sales and Provides Shareholder Update

11/01/2018 - 14:00

Las Vegas, NV, Jan. 11, 2018 (GLOBE NEWSWIRE) -- DLT Resolution Inc. (OTC PINK: HCRED) a blockchain technology company providing distributed ledger technology that services the healthcare and telecommunications [...]

Hooper Holmes Appoints Marc Salois as Chief Revenue Officer

11/01/2018 - 14:00

OLATHE, Kan., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. (OTCQX:HPHW), the nation’s largest publicly-traded pure-play health and well-being solutions provider, announced today that Marc Salois has been named [...]

Immunomedics Announces Agreement with University of Wisconsin Carbone Cancer Center to Expand Sacituzumab Govitecan (IMMU-132) into Prostate Cancer

11/01/2018 - 14:00

Immunomedics to Fund Phase 2 Study Sponsored by the University of Wisconsin to Enable Further Investigation of Sacituzumab Govitecan in the Treatment of Patients with Castration-Resistant Prostate Cancer (CRPC) [...]